S
000520
vs
LLY
LLY
Over the past 12 months, Samil Pharmaceutical Co Ltd has underperformed LLY, delivering a return of -17% compared to the LLY's +13% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
LLY
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Multiples-Based Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
S
|
Samil Pharmaceutical Co Ltd
KRX:000520
|
10 060
KRW
|
|||||
|
Eli Lilly and Co
NYSE:LLY
|
927.03
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
000520, LLY
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
S
|
Samil Pharmaceutical Co Ltd
Revenue
|
|||||||||||
|
|
Eli Lilly and Co
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
000520, LLY
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
S
|
Samil Pharmaceutical Co Ltd
KRX:000520
|
|||||||||
|
|
Eli Lilly and Co
NYSE:LLY
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Samil Pharmaceutical Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Samil Pharmaceutical Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Samil Pharmaceutical Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Samil Pharmaceutical Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Samil Pharmaceutical Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Samil Pharmaceutical Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Samil Pharmaceutical Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
S
|
Samil Pharmaceutical Co Ltd | ||||
|
|
Eli Lilly and Co | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
000520, LLY
Performance Gap
000520, LLY
Performance By Year
000520, LLY
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
